Supporting & Educational Partners
Supporting & Educational Partners
The Trout Group is the leading global investor relations and strategic advisory firm servicing the life sciences industry. Since 1996, the firm has been providing companies with expert counsel and access to the institutional investment community. With two decades of experience in the biotechnology, pharmaceutical, medical technology and life science technology sectors, the Trout Group offers its clients the knowledge base needed to clarify investment themes and leverage key relationships for increased exposure to the proper audience. The firm’s global reach extends through a network of offices in New York, Boston, San Francisco, London, and Shanghai with contacts in all major financial centers, helping clients to connect with the right investors. Visit www.troutgroup.com.
The Association for Cancer Immunotherapy (CIMT) is a members-based information and education platform that facilitates the knowledge exchange between academic and industry scientists, physicians and regulatory authorities who research and develop cancer immunotherapies. CIMT was founded in 2002 by physicians and researchers from different fields of clinical and theoretical medicine as an independent non-profit organization. CIMT has its offices in Mainz, Germany, and is financed by donations, congress fees, industry sponsorships and by public and foundation grants. For more information, visit www.cimt.eu.
Cancer Research Institute is a nonprofit organization dedicated exclusively to the advancement of immunotherapy for cancer. It raises funds and provides research grants to laboratory and clinical scientists who are progressing this field. It also connects patients with cancer immunotherapy clinical trials and with other patients and caregivers considering treatment with immunotherapy. Learn more at www.cancerresearch.org.
Patient Empowerment Network is a non-profit organization dedicated to empowering cancer patients through education and support. We help patients gain the confidence and knowledge to become advocates for themselves and for those in their cancer community. We are here to help them stand up and ask for the best care for themselves. We are here to help them seek out the medical team that is best for them, give them confidence to ask their team about new treatment options, including clinical trials and to help them cope and live well with their illness. Patient Empowerment Network focuses on blood cancers (chronic lymphocytic leukemia, multiple myeloma and myeloproliferative neoplasms), and lung cancer and prostate cancer. For more, see our website here: www.powerfulpati
Established in 1984, the Society for Immunotherapy of Cancer (SITC) is a not-for-profit organization of medical professionals dedicated to improving patient outcomes by advancing the development, science and application of cancer immunotherapy. As the world’s leading member-driven organization dedicated to cancer immunotherapy and tumor immunology, SITC is comprised of nearly 1,000 influential basic and translational scientists, clinicians, health care professionals, government leaders and industry professionals from around the globe. For more information about SITC, please visit www.sitcancer.org.
Since 1993, BioCentury Inc. has been internationally recognized as the leading provider of value-added information, analysis and data for biotechnology and pharmaceutical companies, investors, academia and government on the strategic issues essential to the formation, development and sustainability of life science ventures. BioCentury publishes weekly editions of its flagship publication, BioCentury®, and BioCentury Week in Review, plus daily editions of BioCentury Extra. BioCentury also publishes BioCentury Innovations a weekly translational science journal. The company also markets BCIQ, the industry’s premiere business intelligence and research database. It provides easy access to data on thousands of companies and products and $400+ billion in financings. Learn more at www.biocentury.com.
BioPharm Insight is the most comprehensive life science market intelligence and analytics solution, featuring a team of investigative journalists writing exclusive news and thousands of healthcare data points, aggregated into one centralized source. In addition to the proprietary articles, BioPharm Insight is currently tracking 500,000 management and R&D contacts, 7,500 biopharma companies with full pipeline data, 120,000 investigational and approved drug profiles, 28,000 M&A and licensing deals, 10,000 extended sales forecasts and epidemiology profiles for hundreds of indications. To learn more, visit www.biopharminsight.com and follow us on Twitter @BioPharmInsight
BioPharma Dive provides news and original analysis on the latest happenings in biotech and pharma. Our mission is to provide busy executives with a bird’s-eye-view of the biopharma industry in 60 seconds. With a mobile-optimized daily email newsletter, website, and app, BioPharma Dive keeps you informed on the go. You’ll get coverage of topics such as FDA approvals and regulations, drug discovery, clinical trials, M&A / licensing deals, drug pipelines, contract manufacturing, pharma marketing, and more. Join over 115,000 biotech and pharma executives already enjoying BioPharma Dive: www.
CanBiotech is an open innovation and patient engagement platform for the biotech and pharmaceutical industries. Visit CanBiotech to learn more about best practices for collaboration with industry stakeholders and patients. Participate in the discussion, attend upcoming events and training opportunities provided by CanBiotech and our partners in the areas of innovation program development, open bio-innovation, design thinking for health and patient engagement. For more information, visit www.canbiotech.com.
Endpoints News is an independent news organization, reporting and analyzing the top global biotech and pharmaceutical R&D news of the day. We produce original editorial on a daily basis on business deals, buyouts and corporate reorganizations to FDA actions and the latest clinical data on some of the world’s most closely watched drugs. Visit us at https://endpts.com.
Life Science Leader magazine, a product of the Life Science Connect Media Group, strives to be an essential business tool for life science executives. As such, our content is designed to not only inform readers of industry best practices, but to motivate them to implement those best practices in their own businesses. Each month, Life Science Leader features interviews of executives from the leading pharm and biotech companies, including Merck, Daiichi Sankyo, Genentech, Biogen Idec, Allergan, Pfizer, MedImmune, Genzyme, Eli Lilly, Janssen, the FDA, and more. This exclusive thought leadership provides an in-depth look into industry trends and hot topics that will impact the growth of the pharmaceutical and biopharmaceutical markets. As the market is continually growing and innovating, these insights provide readers with actionable information and strategies to implement when navigating the evolving clinical, manufacturing, entrepreneurial, and regulatory landscapes. Our monthly columns include “Companies to Watch,” “Capital Perspectives,” “Outsourcing Reports,” “Leadership Lessons,” and “Industry Insights.” Learn more at www.lifescienceleader.com.
Pharmalicensing is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique online Showcase Profiling & Discover services, as well as its renowned Partnering Search service leveraging its global network of industry experts, to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing is actively utilized by many tens of thousands of industry professionals each month. Pharmalicensing is a division of IP Technology Exchange, Inc. Learn more at www.pharmalicensing.com.
The leading global provider of thought leadership and insight dedicated to the pharma/healthcare industry, the pharmaphorum channels bring together news, analysis and expert perspectives from all stakeholders in health, including commercial providers, healthcare professionals and patients. This thought-provoking content keeps the pharmaceutical industry informed and connected, driving collaboration and innovation. Visit us at http://pharmaphorum.com and our publication site http://deep-dive.pharmaphorum.com.
PharmaVOICE magazine, reaches more than 41,000 qualified subscribers and 100,000 users with its digital edition. PharmaVOICE is the forum that allows business leaders to engage in a candid dialogue on the challenges and trends impacting the industry. PharmaVOICE provides readers with insightful and thought-provoking commentary in a multiple-perspective format through forums, topics, and articles covering a range of issues from molecule through market. PharmaVOICE subscribers are also kept abreast of the latest trends and information through additional media resources, including Social Media, WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts. Visit www.pharmavoice.com.
STAT is a national publication focused on finding and telling compelling stories about health, medicine, and scientific discovery. We produce daily news, investigative articles, and narrative projects in addition to multimedia features. We tell our stories from the places that matter to our readers — research labs, hospitals, executive suites, and political campaigns. Learn more about www.statnews.com.
Technology Networks is an internationally recognized publisher that provides access to the latest scientific news, products, research, videos and posters. Our global community is made up of over 300,000 researchers and scientific professionals from the life science, drug discover and analytical arenas. Visit www.technologynetworks.com.